VCAM1 and neoplasm: We next tested whether the integrin ligands ICAM-1 and VCAM-1 were expressed by tumor-associated myeloid subsets, with a particular interest in macrophages, monocytes, and cDC2s, the myeloid cell types we previously found promote T-ALL survival14.